Vineet D. Menachery

24.6k total citations · 8 hit papers
86 papers, 7.9k citations indexed

About

Vineet D. Menachery is a scholar working on Infectious Diseases, Animal Science and Zoology and Immunology. According to data from OpenAlex, Vineet D. Menachery has authored 86 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Infectious Diseases, 24 papers in Animal Science and Zoology and 18 papers in Immunology. Recurrent topics in Vineet D. Menachery's work include SARS-CoV-2 and COVID-19 Research (62 papers), Animal Virus Infections Studies (24 papers) and COVID-19 Clinical Research Studies (21 papers). Vineet D. Menachery is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (62 papers), Animal Virus Infections Studies (24 papers) and COVID-19 Clinical Research Studies (21 papers). Vineet D. Menachery collaborates with scholars based in United States, Singapore and China. Vineet D. Menachery's co-authors include Lisa E. Gralinski, Ralph S. Baric, Pei‐Yong Shi, Xuping Xie, Rachel L. Graham, Xianwen Zhang, Boyd L. Yount, Scott C. Weaver, Craig Schindewolf and Jessica A. Plante and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Vineet D. Menachery

81 papers receiving 7.8k citations

Hit Papers

Return of the Coronavirus: 2019-nCoV 2015 2026 2018 2022 2020 2020 2015 2018 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Return of the Coronavirus: 2019-nCoV
    2020 911 citations Lisa E. Gralinski, Vineet D. Menachery profile →
  2. Evasion of Type I Interferon by SARS-CoV-2
    2020 655 citations Hongjie Xia, Xuping Xie et al. profile →
  3. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
    2015 560 citations Vineet D. Menachery, Boyd L. Yount et al. Nature Medicine profile →
  4. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
    2018 479 citations Lisa E. Gralinski, Vineet D. Menachery et al. profile →
  5. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
    2021 383 citations Xuping Xie, Yang Liu et al. Nature Medicine profile →
  6. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission
    2021 341 citations Yang Liu, Jianying Liu et al. profile →
  7. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
    2022 223 citations Yang Liu, Jianying Liu et al. profile →
  8. The variant gambit: COVID-19’s next move
    2021 189 citations Jessica A. Plante, Kenneth S. Plante et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vineet D. Menachery United States 41 6.2k 1.6k 1.3k 1.3k 757 86 7.9k
Benjamin W. Neuman United States 32 6.2k 1.0× 2.0k 1.3× 1.3k 0.9× 823 0.6× 874 1.2× 70 9.1k
Lisa E. Gralinski United States 30 4.1k 0.7× 1.2k 0.8× 834 0.6× 981 0.8× 809 1.1× 53 5.9k
Matthew B. Frieman United States 55 7.0k 1.1× 2.4k 1.5× 1.7k 1.3× 1.8k 1.4× 906 1.2× 112 10.1k
Hin Chu Hong Kong 41 6.3k 1.0× 1.8k 1.1× 755 0.6× 1.3k 1.0× 1.2k 1.6× 126 9.2k
Jincun Zhao China 38 5.9k 0.9× 1.4k 0.9× 1.1k 0.8× 1.6k 1.3× 1.4k 1.9× 138 7.9k
Peng Zhou China 42 6.3k 1.0× 1.6k 1.0× 1.1k 0.8× 1.1k 0.9× 1.0k 1.4× 172 10.4k
Timothy P. Sheahan United States 37 5.9k 0.9× 1.4k 0.9× 817 0.6× 925 0.7× 1.2k 1.6× 84 8.0k
Jian Shang China 19 7.5k 1.2× 2.1k 1.3× 1.0k 0.8× 863 0.7× 1.5k 1.9× 58 9.7k
Anthony R. Fehr United States 27 4.5k 0.7× 1.5k 0.9× 729 0.5× 1.1k 0.9× 927 1.2× 52 6.8k
Kizzmekia S. Corbett United States 16 6.7k 1.1× 2.1k 1.3× 975 0.7× 784 0.6× 814 1.1× 23 8.2k

Countries citing papers authored by Vineet D. Menachery

Since Specialization
Citations

This map shows the geographic impact of Vineet D. Menachery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vineet D. Menachery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vineet D. Menachery more than expected).

Fields of papers citing papers by Vineet D. Menachery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vineet D. Menachery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vineet D. Menachery. The network helps show where Vineet D. Menachery may publish in the future.

Co-authorship network of co-authors of Vineet D. Menachery

This figure shows the co-authorship network connecting the top 25 collaborators of Vineet D. Menachery. A scholar is included among the top collaborators of Vineet D. Menachery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vineet D. Menachery. Vineet D. Menachery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vu, Michelle N., Yiyang Zhou, Kumari G. Lokugamage, et al.. (2025). The furin cleavage site is required for pathogenesis, but not transmission, of SARS-CoV-2. Journal of Virology. 99(7). e0046725–e0046725. 1 indexed citations
2.
Zou, Jing, et al.. (2025). A dual-reporter HCoV-OC43 for coronavirus biology and countermeasure development. Antiviral Research. 244. 106306–106306.
3.
Mugisha, Christian Shema, Vorada Chuenchob, Stephanie Moquin, et al.. (2024). Rapid-response RNA-fluorescence in situ hybridization (FISH) assay platform for coronavirus antiviral high-throughput screening. SLAS DISCOVERY. 29(8). 100189–100189.
4.
Schindewolf, Craig, Kumari G. Lokugamage, Michelle N. Vu, et al.. (2023). SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3. Journal of Virology. 97(2). e0153222–e0153222. 23 indexed citations
5.
Liu, Yang, Xianwen Zhang, Jianying Liu, et al.. (2022). A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Nature Communications. 13(1). 4337–4337. 62 indexed citations
6.
Fiege, Jessica K., Joshua M. Thiede, William E. Matchett, et al.. (2021). Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium. PLoS Pathogens. 17(1). e1009292–e1009292. 47 indexed citations
7.
Muruato, Antonio E., Camila R. Fontes-Garfias, Ping Ren, et al.. (2021). Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nature Communications. 12(1). 4000–4000. 1 indexed citations
8.
Xie, Xuping, Yang Liu, Jianying Liu, et al.. (2021). Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nature Medicine. 27(4). 620–621. 383 indexed citations breakdown →
9.
Graham, Jessica B., Sarah R. Leist, Alexandra Schäfer, et al.. (2021). Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice. PLoS Pathogens. 17(1). e1009287–e1009287. 18 indexed citations
10.
Xie, Xuping, Kumari G. Lokugamage, Xianwen Zhang, et al.. (2021). Engineering SARS-CoV-2 using a reverse genetic system. Nature Protocols. 16(3). 1761–1784. 106 indexed citations
11.
Zhang, Xianwen, Yang Liu, Jianying Liu, et al.. (2021). A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. Cell. 184(8). 2229–2238.e13. 52 indexed citations
12.
Vu, Michelle N. & Vineet D. Menachery. (2021). Binding and entering: COVID finds a new home. PLoS Pathogens. 17(8). e1009857–e1009857. 6 indexed citations
13.
Matchett, William E., Vineet Joag, J. Michael Stolley, et al.. (2021). Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity. The Journal of Immunology. 207(2). 376–379. 102 indexed citations
14.
Muruato, Antonio E., Camila R. Fontes-Garfias, Ping Ren, et al.. (2020). A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nature Communications. 11(1). 4059–4059. 207 indexed citations
15.
Gniadek, Thomas J., Joshua M. Thiede, William E. Matchett, et al.. (2020). SARS‐CoV‐2 neutralization and serology testing of COVID‐19 convalescent plasma from donors with nonsevere disease. Transfusion. 61(1). 17–23. 17 indexed citations
16.
Rostad, Christina A., Ann Chahroudi, Grace Mantus, et al.. (2020). Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C). PEDIATRICS. 146(6). 84 indexed citations
17.
Xie, Xuping, Antonio E. Muruato, Xianwen Zhang, et al.. (2020). A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature Communications. 11(1). 142 indexed citations
18.
Prasanth, K. Reddisiva, Minato Hirano, W. Samuel Fagg, et al.. (2020). Topoisomerase III-β is required for efficient replication of positive-sense RNA viruses. Antiviral Research. 182. 104874–104874. 20 indexed citations
19.
Menachery, Vineet D., Lisa E. Gralinski, Hugh Mitchell, et al.. (2017). Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis. mSphere. 2(6). 86 indexed citations
20.
Pasieka, Tracy Jo, Betty Lu, Seth D. Crosby, et al.. (2008). Herpes Simplex Virus Virion Host Shutoff Attenuates Establishment of the Antiviral State. Journal of Virology. 82(11). 5527–5535. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin W. Neuman Breakdown of academic impact, for papers by Lisa E. Gralinski Breakdown of academic impact, for papers by Matthew B. Frieman Breakdown of academic impact, for papers by Hin Chu Breakdown of academic impact, for papers by Jincun Zhao Breakdown of academic impact, for papers by Peng Zhou Breakdown of academic impact, for papers by Timothy P. Sheahan Breakdown of academic impact, for papers by Jian Shang Breakdown of academic impact, for papers by Anthony R. Fehr Breakdown of academic impact, for papers by Kizzmekia S. Corbett
Rankless by CCL
2026